Venöse Thromboembolien, Thrombophilie und Thromboseprophylaxe in Gynäkologie und Geburtshilfe-Reference-Cited by-同舟云学术

Venöse Thromboembolien, Thrombophilie und Thromboseprophylaxe in Gynäkologie und Geburtshilfe

Published:2017 Issue: Volume: Page:97-112
ISSN:
Container-title:Weiterbildung Gynäkologie und Geburtshilfe
language:
Short-container-title:

Author:

Scharf R.E.,Pestka M.A.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-662-49480-6_10

Reference40 articles.

1. Bates SM, Greer IA, Middeldorp S et al (2012) VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e69–1 S-e736S (PubMed PMID: 22315276. Pubmed Central PMCID: 3278054)

2. Lo GK, Juhl D, Warkentin TE et al (2006) Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Hae- most 4(4):759-765 (PubMed PMID: 16634744)

3. Crowther MA, Cook DJ, Albert M et al (2010) The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients. J Crit Care 25(2):287-293 (PubMed PMID: 20149589)

4. Gerhardt A, Scharf RE, Zotz RB (2009) Successful use of danaparoid in two pregnant women with heart valve prosthesis and heparin-induced thrombocytopenia Type II (HIT). Clin AppI Thromb Hemost 15(4):461-464 (PubMed PMID: 18840630)

5. Gerhardt A, Zotz RB, Stockschlaeder M, Scharf RE (2007) Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids. Thromb Haemost 97(3)496-497 (PubMed PMID: 17334521)